Phytocannabinoids, notably cannabidiol (CBD), tetrahydrocannabinol (THC), and terpenes, have shown the potential to reduce severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) viral infection by downregulating Angiotensin-converting enzyme 2 (ACE2) transcript levels [25]. Here, ACE2 is linked to viral infectious disease.